Skills this job asks for
PharmacyLeadershipFinancial modellingBudgetingStakeholder management
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 191 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 191 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
We’re building a world of health around every individual — shaping a more connected, convenient and compassionate health experience. At CVS Health®, you’ll be surrounded by passionate colleagues who care deeply, innovate with purpose, hold ourselves accountable and prioritize safety and quality in everything we do. Join us and be part of something bigger – helping to simplify health care one person, one family and one community at a time.
Position Summary
CVS Health's Pharmacy Services Finance Team is seeking an Executive Director to lead the Rebate Financial Strategy & Drug Profitability function. This role serves as the strategic finance leader for CVS Health's $70B+ annual rebate portfolio, providing financial stewardship, analytical rigor, and executive-level insight that directly influences pricing strategy, margin optimization, and long-term profitability across the PBM business. The Executive Director is accountable for setting the strategic direction, governance model, and executive decision framework for rebate financial performance and drug-level profitability across the enterprise. This leader will partner closely with VP and CFO leadership, Trade Strategy, Underwriting, and cross-functional stakeholders to shape rebate strategy, govern enterprise-wide drug-level financial assumptions, and translate complex pricing, utilization, contract, and regulatory dynamics into actionable narratives for executive decision-making. This is a high-visibility role that demands equal command of PBM economics, financial modeling, strategic storytelling, transformation leadership, and cross-functional influence.
Major Resonsibilities
1. Rebate Strategy & Financial Planning
• Lead financial strategy, planning, and performance management for the $70B+ rebate portfolio.
• Partner with senior Finance and business leaders to drive margin optimization and long-term profitability.
• Deliver executive insights on financial performance, emerging risks, market dynamics, and regulatory impacts.
• Evaluate key drug and market trends to inform strategic planning and forecast accuracy.
2. Enterprise Assumptions Governance & Standardization
• Establish and govern enterprise-wide financial assumptions and forecasting methodologies.
• Maintain a centralized assumptions framework that drives consistency, transparency, and decision-making.
• Align cross-functional stakeholders on critical drivers impacting pricing, profitability, and growth.
• Strengthen governance and controls to improve forecast accuracy and financial performance.
3. Drug Profitability Analytics & Reporting
• Lead enterprise drug profitability analytics and reporting strategy.
• Develop actionable insights into key profitability drivers, market dynamics, and financial performance.
• Deliver scenario modeling and executive decision support for strategic initiatives and investments.
4. Multi-Year Refresh (MYR) & Trade Capacity Model
• Lead development of the Trade Capacity Model, a key driver of long-term profitability and COGS improvement.
• Direct financial modeling and planning inputs supporting enterprise budget and multi-year forecasting processes.
5. Process Improvement, Innovation & Technology
• Lead finance transformation initiatives that enhance forecasting, reporting, and operational effectiveness.
• Advance analytics, automation, AI, and technology solutions to improve decision-making and productivity.
• Oversee investment governance and portfolio prioritization to maximize business value and financial returns.
• Drive organizational change management and adoption of new operating models and technologies.
6. Leadership, Talent Development & Stakeholder Management
• Build, lead, and develop a high-performing team focused on strategic finance, analytics, a
Apply on employer site ↗